Evidence map›Paper›PMID 39631773›Full record

ArticleACS infectious diseases2024

Integral Solvent-Induced Protein Precipitation for Target-Engagement Studies in

Patricia Bravo, Lorenzo Bizzarri, Dominik Steinbrunn, Jonas Lohse, Anna K H Hirsch, Pascal Mäser, Matthias Rottmann, Hannes Hahne

Abstract read
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A Novel Antimalarial Agent that Inhibits Protein Synthesis in Plasmodium falciparum.Angewandte Chemie (International ed. in English) · 2025
    Article
  2. Article
  3. Review
  4. Advances in Anthelmintic Target Identification.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Patricia BravoSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.ORCID 0000-0001-5454-3826
Lorenzo BizzarriOmicScouts GmbH, Lise-Meitner-Straße 30, D-85354 Freising, Germany.ORCID 0009-0003-7017-5770
Dominik SteinbrunnOmicScouts GmbH, Lise-Meitner-Straße 30, D-85354 Freising, Germany.
Jonas LohseOmicScouts GmbH, Lise-Meitner-Straße 30, D-85354 Freising, Germany.
Anna K H HirschDepartment of Pharmacy, Saarland University, Campus E8.1, D-66123 Saarbrücken, Germany.ORCID 0000-0001-8734-4663
Pascal MäserSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.ORCID 0000-0003-3122-1941
Matthias RottmannSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.
Hannes HahneOmicScouts GmbH, Lise-Meitner-Straße 30, D-85354 Freising, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The limited understanding of the mechanism of action (MoA) of several antimalarials and the rise of drug resistance toward existing malaria therapies emphasizes the need for new strategies to uncover the molecular target of compounds in

Indexed as

AntimalarialsPlasmodium falciparumProteomicsProtozoan ProteinsSolventsTandem Mass SpectrometryChromatography, LiquidHumansMalaria, FalciparumAntimalarialsProtozoan ProteinsSolventsantimalarialdrug discoveryiSPPproteomicssolventstarget-engagement

Identifiers

PMID39631773
PMCPMC11650652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.